|
Jul 25
|
Adicet Bio doses first SSc subject in second cohort of trial evaluating ADI-001
|
|
Jul 24
|
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
|
|
Apr 17
|
Adicet Bio Appoints Michael Grissinger to the Board of Directors
|
|
Mar 31
|
Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Mar 31
|
Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference
|
|
Mar 3
|
Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting
|
|
Feb 27
|
Adicet Bio shares rise on FDA Fast Track Designation for ADI-001
|
|
Feb 27
|
Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)
|
|
Sep 30
|
Adicet Bio to Present at the American Society of Gene & Cell Therapy’s (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference
|
|
Sep 30
|
Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases
|
|
Aug 27
|
Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
|
Aug 1
|
Adicet Bio to Participate in Upcoming Investor Conferences
|
|
Jul 25
|
Why Is Adicet Bio, Inc. (ACET) a Good One-Dollar Stock to Buy According to Hedge Funds?
|
|
Jun 24
|
Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
|
|
Jun 10
|
We're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn Rate
|
|
May 14
|
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
|
|
May 14
|
Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
|
|
May 7
|
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
|
|
Apr 22
|
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
|
|
Apr 8
|
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
|